OncoPharm cover image

PARAMOUNT - Maintenance Pemetrexed

OncoPharm

00:00

PARAMOUNT study design

John Bazar details PARAMOUNT: non‑squamous patients, cisplatin+pemetrexed induction, then pemetrexed maintenance versus placebo.

Play episode from 04:38
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app